2mg INO-5150 and electroporation device CELLECTRA®-5P
PCa-001
Phase 1 mab completed
Quick answer
2mg INO-5150 and electroporation device CELLECTRA®-5P for Prostate Cancer is a Phase 1 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- Prostate Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- completed